Grant: Dissemination Events
Université du Québec à Montréal
$25,000.00
16th International Conference on Human Retrovirology: HTLV and Related Viruses
FY 2012-13
Summary
Laymen summary
The HTLV-1 virus is present worldwide. In Canada, native tribes are particularly infected by this virus. In less than 5% of infected individuals, this virus causes the development of Adult T-cell Leukemia (ATL) and a neurodegenerative disease resembling multiple sclerosis. Unlike HTLV-1, the related HTLV-2 virus does not cause any type of cancer and no satisfactory explanations have been provided for this difference. Two other related viruses termed HTLV-3 and HTLV-4 have also been recently discovered. Other human retroviruses have also been linked to human disease such as primary biliary cirrhoses. Surprisingly, DNA sequences from retroviral origin also known as Human Endogenous Retroviruses are also naturally present in our genome. All of these aspects of human retroviruses will be discussed in this important meeting held each two years and hosted in 2013 by Montréal. Montréal is the first Canadian city to be the host of this meeting, which bears an important aspect to this meeting. The goal of the organizing committee will be to provide a unique environment for scientific exchange and the development of new innovative collaborations. The conference will take place in downtown Montréal from June 26th to June 30th 2013 and will involve a minimum of 300 participants as well as pharmaceutical companies and actors in the public sector. This conference will provide new information over these viruses and will likely generate new avenues for treatment toward the very aggressive ATLL. We are hopeful that these new avenues will have a positive impact on the life expectancy of infected individuals and will likely benefit the health of Native Tribes communities, who remain a more important target for HTLV-1 than other Canadian populations.
Department
Program
Dissemination Events
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
264347
Name
Barbeau Benoit
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Dissemination Events Grants
Projecttitle
16th International Conference on Human Retrovirology: HTLV and Related Viruses
Programtype2
Miscellaneous Programs
Orgnameinp2
Université du Québec à Montréal
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Dissemination Events
Keyworddelim
Conference; Htlv-1 And Htlv-2; Htlv-3 And Htlv-4; Human Endogenous Retroviruses; Mmtv-Like Retrovirus
Abstract
Laymen summary
The HTLV-1 virus is present worldwide. In Canada, native tribes are particularly infected by this virus. In less than 5% of infected individuals, this virus causes the development of Adult T-cell Leukemia (ATL) and a neurodegenerative disease resembling multiple sclerosis. Unlike HTLV-1, the related HTLV-2 virus does not cause any type of cancer and no satisfactory explanations have been provided for this difference. Two other related viruses termed HTLV-3 and HTLV-4 have also been recently discovered. Other human retroviruses have also been linked to human disease such as primary biliary cirrhoses. Surprisingly, DNA sequences from retroviral origin also known as Human Endogenous Retroviruses are also naturally present in our genome. All of these aspects of human retroviruses will be discussed in this important meeting held each two years and hosted in 2013 by Montréal. Montréal is the first Canadian city to be the host of this meeting, which bears an important aspect to this meeting. The goal of the organizing committee will be to provide a unique environment for scientific exchange and the development of new innovative collaborations. The conference will take place in downtown Montréal from June 26th to June 30th 2013 and will involve a minimum of 300 participants as well as pharmaceutical companies and actors in the public sector. This conference will provide new information over these viruses and will likely generate new avenues for treatment toward the very aggressive ATLL. We are hopeful that these new avenues will have a positive impact on the life expectancy of infected individuals and will likely benefit the health of Native Tribes communities, who remain a more important target for HTLV-1 than other Canadian populations.
Competitiondate
201206
Approvedterm2
1 yr 0 mth
Pinamesdelim
Barbeau, Benoit
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $25,000~ $0~